MAESTRO-NASH
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Loading…
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Loading…